Abstract: A method for programming a touch screen of an apparatus is provided. The touch screen includes sensors for sensing locations of inputs and generating corresponding signals, and keys each of which consisting of a group of the sensors. The method includes: designing a group of the sensors as a key; setting an associated function to the designed key; generating a layout file of the designed keys; showing the layout file to prompt position and the associated function of each of the keys; acquiring the associated functions according to the key indicated by the signals; and executing the acquired functions.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.

Abstract: Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands, Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).

Abstract: A data storage medium includes a first storage unit and a second storage unit. The first storage unit is used to store a target electronic device ID, the second storage unit stores software installation data. The software installation data includes a copyright protection module, a software installation program, and a software data. When the software installation data is invoked to install the software data, the copyright protection module is invoked and automatically runs. The copyright protection module accesses the first storage unit and reads the target electronic device ID. The software data can be installed in the target electronic device only if the first storage unit contained the target electronic device ID or the first storage unit is writable and the target electronic device ID is stored in the first storage unit successfully.

Abstract: A multi-functional wireless mouse (1) includes a mouse body 2 and a circuit board 3. A scrolling wheel (11), a plurality of selection button (12), an earphone jack (13), a microphone (14), a speaker (15) and a laser led (16) are mounted on the mouse body 2. The circuit board 3 includes: a wireless module (30), an audio amplifying circuit (403) for amplifying an analog audio signal, an audio output unit (401) for outputting the amplified analog audio signal, and an audio input unit (402) for inputting an analog audio signal. The advantage of the present invention is that the multi-functional wireless mouse (1) can receives a wireless audio signal sent by a computer through a wireless transceiver module (301) and sends wireless audio signal to the computer, and wireless operates the computer. Additionally, the mouse (1) can be used as a pointer.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.

Abstract: The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.

Abstract: A media player is provided. The media player is not only capable of automatically backing up information from a mobile phone and deleting predetermined backupped information from the mobile phone, but is also capable of preventing others accessing the backupped information. The media player includes a memory, a communication unit, a signal processing module, and a user identification module. The memory stores a contact list and short messages. The communication unit is configured for communicating with a paired communication unit of a mobile phone. The signal processing module is configured for processing signals generated from the paired communication unit. The user identification module is configured for granting or denying access to the contact list and the short messages stored in the memory, depending on whether an inputted password matches a predetermined password or not.

Abstract: The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of treating pain using these compounds and pharmaceutical compositions including these compounds.

Abstract: A video surveillance system includes a video camera, a display device, and a control apparatus. The video camera is used for capturing video images. The display device is used for displaying the video images. The control apparatus is used for controlling the video camera. The control apparatus includes a detector and a processing module. The detector is used for detecting an event and generating an event detected signal corresponding to the event. The processing module is used for enabling the video camera based on the event detected signal.

Abstract: A method for programming a touch screen of an apparatus is provided. The touch screen includes sensors for sensing locations of inputs and generating corresponding signals, and keys each of which consisting of a group of the sensors. The method includes: designing a group of the sensors as a key; setting an associated function to the designed key; generating a layout file of the designed keys; showing the layout file to prompt position and the associated function of each of the keys; acquiring the associated functions according to the key indicated by the signals; and executing the acquired functions.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2, and L are defined in the description.

Abstract: The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.

Abstract: The isoquinoline compounds of formula (I) are VR1 antagonists that are useful in treating pain, inflammation, thermal hyperalgesia, urinary incontinence and bladder over activity. The “R”, “Z” and “L” variables are defined in the disclosure and the “X” variables are defined as follows: X1 is CR1; X2 is selected from the group consisting of N and CR2; X3 is selected from the group consisting of N and CR3; X4 is CR4; and X5 is selected from the group consisting of N and C.

Abstract: Compounds of formula (I) are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity, wherein X1, X2, X3, X4, X5, R5, R6, R7, R8a, R8b, R9, Z1, Z2 and L are as defined in the description.

Abstract: Compounds of formula (I) are novel P2X3 and P2X2/P2X3 antagonists which are useful in treating pain, urinary incontinence and bladder overactivity.

Abstract: Compounds of formula (I) 1